Cationic lipid-DNA complexes in gene delivery: from biophysics to biological applications

Advanced Drug Delivery Reviews
M C Pedroso de LimaN Düzgüneş

Abstract

Great expectations from the application of gene therapy approaches to human disease have been impaired by the unsatisfactory clinical progress observed. Among others, the use of an efficient carrier for nucleic acid-based medicines is considered to be a determinant factor for the successful application of this promising therapeutic strategy. The drawbacks associated with the use of viral vectors, namely those related with safety problems, have prompted investigators to develop alternative methods for gene delivery, cationic lipid-based systems being the most representative. This review focuses on the various parameters that are considered to be crucial to optimize the use of cationic lipid-DNA complexes for gene therapy purposes. Particular emphasis is devoted to the analysis of the different stages involved in the transfection process, from the biophysical aspects underlying the formation of the complexes to the different biological barriers that need to be surpassed for gene expression to occur.

References

Jan 26, 1989·Nature·P L Felgner, G M Ringold
Sep 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·J P BehrJ Perez-Mutul
Nov 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·P L FelgnerM Danielsen
Jun 2, 1987·Biochemistry·N K SubbaraoK Pongracz
Nov 1, 1995·Transgenic Research·R L PageW H Velander
Aug 11, 1995·The Journal of Biological Chemistry·J ZabnerM J Welsh
May 4, 1995·Biochimica Et Biophysica Acta·I Wrobel, D Collins
Nov 27, 1995·Annals of the New York Academy of Sciences·P L FelgnerS H Cheng
Dec 20, 1995·Biochimica Et Biophysica Acta·P CsermelyI Szántó
Apr 5, 1996·Biochemical and Biophysical Research Communications·N K EgilmezR B Bankert
Aug 1, 1996·Biophysical Journal·S W HuiK Chan
Oct 15, 1996·Proceedings of the National Academy of Sciences of the United States of America·C J WheelerS H Cheng
Nov 1, 1996·Pharmaceutical Research·F D Ledley
Apr 3, 1997·Biochimica Et Biophysica Acta·S J EastmanR K Scheule
Apr 3, 1997·Biochimica Et Biophysica Acta·T Stegmann, J Y Legendre
Jul 1, 1997·Nature Biotechnology·N S TempletonG N Pavlakis
May 30, 1997·Chemistry and Physics of Lipids·T PaukkuP K Kinnunen
Jul 1, 1997·Pharmaceutical Research·R I MahatoE Tomlinson
Feb 12, 1998·Gene Therapy·F L SorgiL Huang
Feb 12, 1998·Gene Therapy·C M GormanJ P Wiener-Kronish
Nov 25, 1997·Biophysical Journal·S May, A Ben-Shaul
Jan 7, 1998·Nature Biotechnology·H DengP A Khavari
Mar 21, 1998·Human Gene Therapy·M E FerrariP L Felgner

❮ Previous
Next ❯

Citations

Sep 12, 2002·Journal of Physiology and Biochemistry·A RochaJ M Coll
Oct 19, 2006·European Biophysics Journal : EBJ·Alexander J Wagner, Sylvio May
Sep 19, 2009·Genetica·Romain LabasBruno Pitard
Apr 1, 2006·Journal of Fluorescence·Elisabete M S CastanheiraMaria-João R P Queiroz
Mar 3, 2010·Journal of Fluorescence·Elisabete M S CastanheiraMaria-João R P Queiroz
Mar 28, 2007·Pharmaceutical Research·Verena Russ, Ernst Wagner
Dec 20, 2003·Journal of Controlled Release : Official Journal of the Controlled Release Society·Anas El-Aneed
Apr 25, 2003·Journal of Controlled Release : Official Journal of the Controlled Release Society·Y K LuuM Hadjiargyrou
Sep 3, 2002·Advanced Drug Delivery Reviews·Thomas MerdanThomas Kissel
Feb 5, 2003·Advanced Drug Delivery Reviews·Virginie EscriouPierre Wils
Oct 9, 2002·Current Opinion in Neurobiology·Philip Washbourne, A Kimberley McAllister
Apr 20, 2002·Drug Discovery Today·Manfred Ogris, Ernst Wagner
Oct 29, 2002·Bioelectrochemistry·R I ZhdanovV V Vlassov
Mar 1, 2012·Bioconjugate Chemistry·Kenji KonoAtsushi Harada
Feb 18, 2011·Biomacromolecules·Jianjun ZhangTatiana Segura
Aug 1, 2007·ACS Nano·Alexander N ZelikinFrank Caruso
Aug 26, 2009·Lab on a Chip·Albert Tsung-Hsi HsiehAbraham P Lee
Nov 16, 2010·Photochemistry and Photobiology·Sergii RudiukIsabelle Rico-Lattes
Jun 30, 2011·Nanoscale Research Letters·Elisabete Ms CastanheiraMaria-João Rp Queiroz
Sep 9, 2005·The AAPS Journal·Siddhesh D PatilDiane J Burgess
Apr 6, 2007·The AAPS Journal·Xiang GaoDexi Liu
Jul 3, 2013·Biological & Pharmaceutical Bulletin·Makoto Oba
Mar 21, 2012·Critical Reviews in Biomedical Engineering·Carolyn L Waite, Charles M Roth
Nov 25, 2011·International Journal of Nanomedicine·Praneet OpanasopitUracha Ruktanonchai
May 27, 2010·Indian Journal of Pharmaceutical Sciences·P SaraswatB P Nagori
Jan 19, 2007·The Journal of Chemical Physics·F BordiD Viscomi
Nov 30, 2013·International Journal of Pharmaceutics·D IbraheemH Fessi
Feb 21, 2003·Proceedings of the National Academy of Sciences of the United States of America·Qing GeJianzhu Chen
Jun 9, 2006·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Luc WasunguDick Hoekstra
Oct 15, 2013·New Biotechnology·Rita CortesiElisabetta Esposito
Jul 26, 2014·International Journal of Nanomedicine·Marta PassadouroHenrique Faneca
Dec 1, 2013·Drug Delivery and Translational Research·Rajan SwamiSistla Ramakrishna
Feb 15, 2014·Drug Delivery·Shivani Rai PaliwalSuresh P Vyas
Nov 22, 2005·Expert Opinion on Drug Delivery·Sérgio SimõesMaria Pedroso de Lima
Jan 10, 2016·Advanced Drug Delivery Reviews·Jinhwan KimWon Jong Kim
Feb 24, 2016·International Journal of Pharmaceutics·Nada MatouguiPatrick Saulnier
Feb 19, 2013·International Journal of Pharmaceutics·Srinath GovindarajanVijaya Gopal
Sep 3, 2013·Journal of Pharmaceutical Sciences·Jonathan De La VegaDuarte Miguel F Prazeres
Jul 14, 2012·Biomaterials·Min JiangYong Gan

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.